Announcement • Apr 22
Norman Broadbent plc, Annual General Meeting, May 20, 2026 Norman Broadbent plc, Annual General Meeting, May 20, 2026. Location: the offices of cavendish capital markets limited, one bartholomew close, ec1a 7bl, london United Kingdom Announcement • Apr 20
Norman Broadbent plc Announces Appointment of Dr. Annette Nabavi as Independent Non-Executive Director, Effective May 1, 2026 Norman Broadbent PLC announces the appointment of Dr. Annette Nabavi to the Board as an independent non-executive director with effect from May 1, 2026. Annette will assume the roles of Chair of the Remuneration Committee and member of the Audit Committee upon appointment. Annette brings over 30 years of experience in operational and advisory roles including driving growth through team building and international diversification, and through acquisition and partnerships. Annette currently sits on the boards of Eleco plc and Iomart Group plc, two AIM companies. At Eleco, Annette is Senior Independent Director, Chair of the Remuneration Committee and is a member of the Audit & Risk, the Nominations and the Environmental, Social & Governance Committees. At Iomart, Annette is Chair of the Remuneration Committee and is a member of the Audit and the Nominations Committees. She has held several other non-executive director roles, including at Maintel Holdings Plc, where she also chaired the Remuneration Committee. Her remuneration experience is also reflected in her involvement with the Quoted Companies Alliance (QCA), where she supported the update to the Remuneration Committee Guide published in 2021. Annette is Finance Director for Women in Telecoms and Technology, a Not-for-Profit organisation. The Board is looking to appoint a further independent non-executive director in due course. The following additional information is provided with regards to the appointment of Annette Patricia Nabavi (née Lane), aged 74, in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies: Current Directorships: Eleco plc, Iomart Group plc, Women in Telecoms and Technology (WITT) Ltd. Previous Directorships held in the past five years: EFI Group Ltd, Maintel Group plc, Anchusa Consulting Ltd, Talan UK & Ireland Limited. Reported Earnings • Apr 20
First half 2025 earnings released: EPS: UK£0.27 (vs UK£0.04 loss in 1H 2024) First half 2025 results: EPS: UK£0.27 (up from UK£0.04 loss in 1H 2024). Revenue: UK£7.44m (up 48% from 1H 2024). Net income: UK£499.0k (up UK£572.0k from 1H 2024). Profit margin: 6.7% (up from net loss in 1H 2024). The move to profitability was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 4 years, compared to a 6.3% growth forecast for the Professional Services industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. New Risk • Apr 08
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2024 fiscal period end). Market cap is less than US$10m (UK£4.14m market cap, or US$5.57m). Announcement • Mar 09
Norman Broadbent plc to Report Fiscal Year 2025 Final Results on Mar 25, 2026 Norman Broadbent plc announced that they will report fiscal year 2025 final results on Mar 25, 2026 Announcement • Feb 25
Norman Broadbent plc (AIM:NBB) acquired Society Limited for £0.03 million. Norman Broadbent plc (AIM:NBB) acquired Society Limited for £0.03 million on February 25, 2026. The consideration consists of 0.01 million common equity of Norman Broadbent plc to be issued for common equity of Society Limited. As part of consideration, £0.03 million is paid towards common equity of Society Limited. The acquisition is being completed on a debt and cash free basis. As part of the acquisition, Norman is issuing 14,194 new ordinary shares at £0.05 each to the vendor, contingent upon their admission to trading on AIM, which is anticipated to occur on March 3, 2026. These new shares are subject to a 12-month lock-up period with exceptions allowed under certain conditions, and an additional 6-month orderly marketing restriction thereafter.
As of January 31, 2026, Society Limited reported gross assets of £0.1 million.
Julian Blunt, Seamus Fricker, Jasper Berry, Matthew Lewis of Cavendish Capital Markets Limited acted as financial advisor and Broker for Norman Broadbent plc.
Norman Broadbent plc (AIM:NBB) completed the acquisition of Society Limited on February 25, 2026. New Risk • Oct 24
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£4.65m market cap, or US$6.19m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Announcement • Aug 19
Norman Broadbent plc to Report First Half, 2025 Results on Sep 08, 2025 Norman Broadbent plc announced that they will report first half, 2025 results on Sep 08, 2025 Announcement • Apr 23
Norman Broadbent plc, Annual General Meeting, May 22, 2025 Norman Broadbent plc, Annual General Meeting, May 22, 2025. Location: the offices of one advisory limited, temple chambers, 3 7 temple avenue, ec4y 0dt, london United Kingdom Reported Earnings • Apr 09
Full year 2024 earnings released: UK£0.002 loss per share (vs UK£0.005 profit in FY 2023) Full year 2024 results: UK£0.002 loss per share (down from UK£0.005 profit in FY 2023). Revenue: UK£10.9m (down 11% from FY 2023). Net loss: UK£158.0k (down 151% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. New Risk • Mar 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£1.66m market cap, or US$2.15m). Minor Risks High level of debt (49% net debt to equity). Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Announcement • Mar 04
Norman Broadbent plc to Report Fiscal Year 2024 Results on Apr 02, 2025 Norman Broadbent plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 02, 2025 New Risk • Jan 31
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (UK£1.92m market cap, or US$2.38m). Minor Risk High level of debt (49% net debt to equity). New Risk • Nov 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£3.03m market cap, or US$3.81m). Minor Risks High level of debt (49% net debt to equity). Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (3.3% increase in shares outstanding). New Risk • Sep 21
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£3.67m market cap, or US$4.89m). Minor Risks High level of debt (49% net debt to equity). Share price has been volatile over the past 3 months (7.6% average weekly change). Shareholders have been diluted in the past year (3.3% increase in shares outstanding). New Risk • Sep 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (UK£4.31m market cap, or US$5.70m). Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Shareholders have been diluted in the past year (3.3% increase in shares outstanding). New Risk • Apr 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£6.71m market cap, or US$8.43m). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (5.1% increase in shares outstanding). Announcement • Mar 29
Norman Broadbent plc, Annual General Meeting, May 23, 2024 Norman Broadbent plc, Annual General Meeting, May 23, 2024, at 10:00 Coordinated Universal Time. Location: Company's offices at 7th Floor Millbank Tower, 21-24 Millbank London United Kingdom Reported Earnings • Mar 29
Full year 2023 earnings released: EPS: UK£0.005 (vs UK£0.006 loss in FY 2022) Full year 2023 results: EPS: UK£0.005 (up from UK£0.006 loss in FY 2022). Revenue: UK£12.3m (up 42% from FY 2022). Net income: UK£309.0k (up UK£647.0k from FY 2022). Profit margin: 2.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. New Risk • Mar 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£6.03m market cap, or US$7.62m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (8.0% average weekly change). Announcement • Mar 21
Norman Broadbent plc to Report Fiscal Year 2023 Final Results on Mar 27, 2024 Norman Broadbent plc announced that they will report fiscal year 2023 final results on Mar 27, 2024 New Risk • Feb 09
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£4.64m market cap, or US$5.85m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Reported Earnings • Jul 26
First half 2023 earnings released: EPS: UK£0 (vs UK£0.001 loss in 1H 2022) First half 2023 results: EPS: UK£0 (improved from UK£0.001 loss in 1H 2022). Revenue: UK£6.06m (up 54% from 1H 2022). Net income: UK£8.0k (up UK£80.0k from 1H 2022). Profit margin: 0.1% (up from net loss in 1H 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 3% per year. Announcement • Jun 06
Norman Broadbent plc, Annual General Meeting, Jun 29, 2023 Norman Broadbent plc, Annual General Meeting, Jun 29, 2023, at 10:00 Coordinated Universal Time. Location: 7th Floor Millbank Tower, 21-24 Millbank, London SW1P 4QP London United Kingdom Reported Earnings • Jun 02
Full year 2022 earnings released: UK£0.006 loss per share (vs UK£0.011 loss in FY 2021) Full year 2022 results: UK£0.006 loss per share (improved from UK£0.011 loss in FY 2021). Revenue: UK£8.70m (up 33% from FY 2021). Net loss: UK£338.0k (loss narrowed 47% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Announcement • Jun 01
Norman Broadbent plc Announces Directorate Changes Norman Broadbent plc announced the appointment of Jon Kempster as an independent Non-Executive Director and that Fiona McAnenawill not be standing for re-election as a Non-Executive Director at the Company's upcoming Annual General Meeting. Jon Kempster will replace Devyani Vaishampayan as Chair of the Company's Audit Committee and will join the Remuneration Committee. Devyani Vaishampayan replaces FionaMcAnenaas Chair of the Remuneration Committee. Jon has more than 20 years' experience as a public company director. He is currently a Non-Executive Director of AIM quoted DX (Group) plc, the provider of delivery solutions, FireAngel Safety Technology plc, the home safety products group, and Serinus Energy Plc, the international oil and gas company. He is also a Director of Delta Pension Nominees Limited. Jon qualified as a chartered accountant with Price Waterhouse in 1990 and has held several board positions in both an executive and non-executive capacity, including at Redcentric plc, Frasers Group plc and more recently Ted Baker plc. Announcement • Jan 10
Norman Broadbent plc Announces Chief Financial Officer Changes Norman Broadbent plc announced the appointment of Mehr Malik as its Chief Financial Officer with effect from 16 January 2023 to replace Steve Smith. Mehr is a qualified chartered accountant who trained with KPMG and has held various financial and commercial leadership roles with a range of businesses, including international high growth management consulting firms. She has a proven track record of developing teams and delivering sustainable and profitable business growth both organically and inorganically. Most recently, she has acted as portfolio CFO/FD directly and through Isosceles Finance, the provider of accounting outsourcing, FD services and M&A advisory. Prior to that she was CFO at Clarasys Limited and Finance Manager atBAE Systems Digital Intelligence(formerly known as BAE Systems Applied Intelligence and previously Detica). Mehr holds a degree in Applied Psychology from Cardiff University. As set out in the Company's announcement of 23 August 2022, Steve Smith will remain with the Company for approximately five weeks following Mehr's appointment to facilitate a smooth handover and transition. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Devyani Vaishampayan was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Nov 01
Norman Broadbent plc Announces Peter Searle as Non-Executive Chairman Norman Broadbent plc announced that the role of Peter Searle who was appointed as its Executive Chairman on 15 June 2021 has changed to Non-Executive Chairman with immediate effect. Peter remains fully committed to the Company, will continue to stay involved in the business and lead the Board with a particular focus on strategic initiatives. Announcement • Aug 23
Norman Broadbent plc Announces Resignation of Steve Smith as Director Norman Broadbent plc announced that Steve Smith, its Group CFO and COO, has resigned as a Director of the Company to pursue other business opportunities. The search for a replacement has commenced and Steve, who has a 6 month notice period, has agreed to remain with the Company to ensure a smooth transition. Reported Earnings • Aug 18
First half 2022 earnings released: UK£0.001 loss per share (vs UK£0.003 loss in 1H 2021) First half 2022 results: UK£0.001 loss per share (up from UK£0.003 loss in 1H 2021). Revenue: UK£3.94m (up 27% from 1H 2021). Net loss: UK£72.0k (loss narrowed 50% from 1H 2021). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Reported Earnings • Jun 12
Full year 2021 earnings released: UK£0.011 loss per share (vs UK£0.006 loss in FY 2020) Full year 2021 results: UK£0.011 loss per share (down from UK£0.006 loss in FY 2020). Revenue: UK£6.55m (down 16% from FY 2020). Net loss: UK£642.0k (loss widened 99% from FY 2020). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Announcement • May 21
Norman Broadbent plc to Report Fiscal Year 2021 Results on May 23, 2022 Norman Broadbent plc announced that they will report fiscal year 2021 results on May 23, 2022 Board Change • Apr 27
No independent directors There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. No independent directors (6 non-independent directors). Non-Executive Director Fiona McAnena is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Sep 29
First half 2021 earnings released: UK£0.003 loss per share (vs UK£0.003 loss in 1H 2020) The company reported a soft first half result with weaker revenues and control over costs, although losses reduced. First half 2021 results: Revenue: UK£3.10m (down 30% from 1H 2020). Net loss: UK£143.0k (loss narrowed 18% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Announcement • Oct 06
Norman Broadbent plc (AIM:NBB) agreed to acquire remaining 25% stake in Norman Broadbent Interim Management Limited from Angela Hickmore for £0.14 million. Norman Broadbent plc (AIM:NBB) agreed to acquire remaining 25% stake in Norman Broadbent Interim Management Limited from Angela Hickmore for £0.14 million on October 5, 2020. As part of the transaction, the total consideration to be satisfied by the payment of the initial cash consideration of £0.065 million at completion and the issue of consideration shares value of £0.07 million. On October 5, 2020, Norman Broadbent plc has issued and allotted approximately 1.3 million ordinary shares of 1 pence each ("Consideration Shares") pursuant to the acquisition of Norman Broadbent Interim Management Limited. The consideration shares will rank pari passu in all respects with the Norman Broadbent plc existing ordinary shares of 1 pence each.